| Literature DB >> 35037590 |
Kenneth Yakubu1, Andrea Durbach2, Alexandra van Waes3, Sikhumbuzo A Mabunda1,4, David Peiris1, Janani Shanthosh1,2, Rohina Joshi4,5.
Abstract
BACKGROUND: Governments worldwide participate in skilled health worker (SHW) migration agreements to protect access to health services in their countries. Previous studies have described the value offered by these agreements in separate source and destination country perspectives.Entities:
Keywords: Health workforce; Immigration; emigration; governance
Mesh:
Year: 2022 PMID: 35037590 PMCID: PMC8765257 DOI: 10.1080/16549716.2021.2013600
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Figure 1.Summary of search, selection and inclusion process.
Figure 2.List of countries reflected in the reviews.
Distribution of content areas from the primary studies included in the review
| Area of inquiry based on the framework | Category | Sub-categories | Number of articles (%) |
|---|---|---|---|
| Public Value proposition | |||
| Facilitate SHW mobility between countries | -Part of broad initiatives aimed at securing economic value for both source & destination countries | 34 (53.9%) | |
| Achieve health workforce sustainability | -Track workforce needs and migration flows. | 14 (22.2%) | |
| | Build capacity for SHW migration governance | -Monitoring of migration flows and their impact | 9 (14.3%) |
| Competing Public Values | | | |
| Patient safety in destination countries | -Concerns about quality of SHWs attracted, and its impact on patient safety | 10 (15.9%) | |
| SHW shortages in destination countries | -Addressing SHW shortages in destination countries, less concern on impact in source countries | 15 (23.8%) | |
| Handling Competing Public Values | |||
| Equality and equity | -Mitigating negative effects of migration | 43 (68.3%) | |
| Protecting a country’s autonomy | -State parties exercise regulatory discretion to protect their county’s public health interests. | 34 (54.0%) | |
| A focus on cooperation | -Seeking to forge solidarity between state parties | 18 (28.6%) | |
| Delegating authority to a regional governance system | -A regional council is recognised as the unbiased arbiter on competing interests between state parties | 3 (4.8%) | |
| Enabling/Constraining factors | |||
| Authorising environment | Alignment of interests/prevailing social pressure | 4 (6.3%) | |
| Capacity to harness available resources | Implementation mechanisms | 19 (30.2%) |
*SHW – Skilled Health Workers
Figure 3.Public values and competing public values in SHW migration governance.
Figure 4.Handling competing public values in the global governance of SHW migration.
Figures 5.Enablers and constraints in creating public value and handling competing public values in the global governance of SHW migration.
| Migration |
|---|
| 1. brain drain.mp. or migration.sh. or emigration.sh. or immigration.sh |
| Health professionals |
| 2. (skilled and (health* or medical) and (profession* or personnel or staff or worker* or manpower or workforce)).mp. |
| 3. nurse*.mp. |
| 4. physician*.mp. |
| 5. doctor*.mp. |
| 6. dentist*.mp. |
| 7. (midwife* or midwiv*).mp. |
| 8. pharmacist.mp. |
| 9. 2 or 3 or 4 or 5 or 6 or 7 or 8 |
| Governance |
| 10. (governance or government).sh. |
| 11. administration.sh. |
| 12. decision making.sh. |
| 14. regulation.sh. or regulation*.mp. |
| 15. (health policy or regional policy).sh. or policy.mp. or policies.mp. or policy.sh. or government policy.sh. or policy respons*.mp. or intervention*.mp. or agreements.mp. or regulation.mp. |
| 16. planning.mp. or planning.sh. or work planning.sh. |
| 17. 10 or 11 or 12 or 13 or 14 or 15 or 16 |
| Health professionals AND Migration AND Governance |
| 18. 1 and 9 and 17 |
| Migration |
|---|
| S1 ‘brain drain’“ |
| S2 migration |
| S3 (MH ‘Emigration and Immigration/LJ/EI’) |
| S4 S1 or S2 or S3 |
| Health professionals |
| S5 health professional |
| S6 health personnel |
| S7 health staff |
| S8 health worker |
| S9 health manpower |
| S10 “health workforce “ |
| S11 nurse |
| S12 doctor |
| S13 physician |
| S14 pharmacist |
| S15 dentist |
| S16 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 |
| Governance |
| S17 (MH ‘State Government’) OR (MH ‘Government’) OR ‘governance’ |
| S18 administration |
| S19 ‘decision making’ |
| S20 (MH ‘Professional Regulation’) OR (MH ‘Rules and Regulations’) OR (MH ‘Government Regulations’) OR ‘regulation’ |
| S21 (MH ‘Public Policy’) OR (MH ‘Policy Making’) OR (MH ‘Health Policy’) OR ‘policy’ |
| S22 ‘intervention’ |
| S23 (MH ‘International Business’) OR (MH ‘Negotiation’) OR ‘agreements’ |
| S24 (MH ‘Strategic Planning’) OR ‘planning’ |
| S25 S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S22 OR S23 OR S24 |
| Health professionals AND Migration AND Governance |
| S30 S4 AND S16 AND S25 |
| Content areas | |||||||
|---|---|---|---|---|---|---|---|
| First Author (Year of Publication) | Study design /article type | Level of governance | PVP | AE | OC | CPV¥ | HaCPV¥ |
| Abuagla, A. (2016)(1) | Case study | Bilateral | * | * | * | * | |
| Arnold, P.C. (2011)(2) | Essay | Bilateral | * | * | * | ||
| Balasubramanian, M. (2016)(3) | Qualitative study | Bilateral Regional International | * | * | * | ||
| Balasubramanian, M. (2011)(4) | Qualitative study | International | |||||
| Bidwell, P. (2014)(5) | Qualitative Content Analysis | Bilateral | * | * | |||
| Brush, B.L. (2008)(6) | Integrative Literature Review | Bilateral International | * | * | |||
| Brush, B.L. (2010)(7) | Historical analysis | Bilateral | * | * | |||
| Buchan, J. (2010)(8) | Analytical Review | International | * | * | |||
| Buchan, J. (2011)(9) | Editorial | International | * | * | * | ||
| Buchan, J. (2003)(10) | Report | Regional, International | * | * | |||
| Cheng, M.H. (2009)(11) | Report | Bilateral | * | * | |||
| Connell, J. (2011)(12) | Analytical Review | Bilateral Regional International | * | * | * | * | * |
| Cowan, D. (2006)(13) | Editorial | Regional | * | * | * | ||
| Dhillon, I.S. (2010)(14) | Book | Bilateral Regional International | * | * | * | * | |
| Ennis, C.A. (2018)(15) | Transnational Analysis | Bilateral | * | * | * | ||
| European Observatory on HealthSystems and Policies (2014)(16) | Book | Bilateral Regional International | * | * | * | ||
| Gerlinger, T. (2007)(17) | Analytical Review | Regional | * | * | * | * | * |
| Hawthorne, L. (2015)(18) | Project report | Bilateral Regional International | * | * | * | * | |
| Jourdain, A. (2017)(19) | Review | Regional | * | * | |||
| Kalipeni, E. (2012)(20) | Analytical Review | Bilateral | |||||
| Kanchanachitra, C. (2011)(21) | Review | Bilateral Regional International | * | * | * | * | |
| Kingma, M. (2001)(22) | Commentary | Bilateral Regional International | * | * | * | ||
| Kingma, M. (2006)(23) | Meeting Presentation | Bilateral Regional International | * | * | * | ||
| Kupfer, L. (2004)(24) | Program report | Bilateral Regional International | * | * | * | ||
| Lewis, P. (2011)(25) | Case Study | Bilateral Regional International | * | * | |||
| Ling, K. (2014)(26) | Commentary | Bilateral Regional | * | * | * | ||
| Lofters, A.K. (2012)(27) | Commentary | Bilateral Regional International | * | * | * | ||
| Makulec, A (2014)(28) | Working Paper Series | Bilateral | * | * | * | ||
| Manning, C. (2007)(29) | Case study | Regional International | * | ||||
| Morgan, W.J. (2005)(30) | Case Study | International | * | * | * | ||
| Nullis-Kapp, C. (2005)(31) | WHO News Bulletin | Bilateral | * | ||||
| Ognyanova, D. (2012)(32) | Mixed-Methods Qualitative Study | Bilateral Regional International | * | * | * | * | |
| Pagett, C. (2007) (33) | Review | Bilateral Regional International | * | * | * | * | |
| Pastor‐Bravo, M. (2019)(34) | Case Study | Bilateral | * | * | * | ||
| Plotnikova, E.V. (2012)(35) | Document analysis & Qualitative Interviews | Bilateral | * | * | * | * | * |
| Plotnikova, E.V. (2012)(36) | Qualitative Content Analysis | Bilateral | * | * | * | * | |
| Reardon, C. (2014)(37) | Qualitative study | Bilateral | * | ||||
| Salmon, M.E. (2007)(38) | Program Report | Bilateral | * | * | |||
| Simoens, S. (2005)(39) | Working Paper | Bilateral Regional International | * | ||||
| Siyam, A (2013)(40) | Progress report | Bilateral Regional International | * | * | * | * | |
| Squires, A. (2011)(41) | Qualitative study | Regional | * | * | |||
| Stilwell, B. (2004)(42) | Commentary | Bilateral Regional International | * | * | |||
| Tangcharoensathien, V. (2015)(43) | Commentary | Bilateral Regional International | * | * | |||
| Tangcharoensathien, V. (2017)(44) | Qualitative Policy analysis | Bilateral | * | * | |||
| Tankwanchi, A.B.S (2014)(45) | Correspondence | International | * | ||||
| Te, V. (2018)(46) | Scoping Review | Regional | * | * | * | * | |
| Tsujita, Y. (2017)(47) | Research Report | Bilateral | * | * | * | ||
| Villegas, B.M (1993)(48) | Narrative Review | Regional | * | * | |||
| Walton-Roberts, M.J. (2020)(49) | Book Chapter | Bilateral, International | * | ||||
| Wangchuk, K. (2015)(50) | Brief Communication | Bilateral | * | ||||
| Willetts, A. (2004)(51) | Review | International | * | * | * | ||
| World Health Organization, Regional Office for The Western Pacific (2003)(52) | Meeting Report | Bilateral | * | * | * | ||
| WHO (2003)(53) | Report | International | * | * | |||
| World Health Organization (2006)(54) | Report | Bilateral Regional International | * | * | |||
| World Health Organization Regional Committee for Africa. (2009)(55) | Technical Report | International | * | * | * | * | * |
| World Health Organization Regional Office for South-East Asia. (2009)(56) | Technical Paper | International | * | * | * | * | |
| World Health Organization Regional Office for the Western Pacific. (2003)(57) | Meeting Report | Bilateral | * | * | |||
| World Health Organization Regional Office for the Western Pacific (2013)(58) | Analytical Review | Regional, | * | * | |||
| Yagi, N. (2014)(59) | Policy Analysis | Bilateral Regional International | * | * | * | * | |
| Yeates, N (2013)(60) | International Policy Report | Bilateral Regional International | * | * | * | * | |
| Yeates, N. (2018)(61) | Analytical Review | Bilateral Regional International | * | * | * | * | |
| Yeates, N. (2019)(62) | Research Monograph | Bilateral Regional International | * | * | * | * | * |
| Young, R. (2013)(63) | Evaluation Study (Mixed Methods) | Bilateral | * | * | * | * | |
Key: PVP – public value proposition, AE – authorising environment, OPC – operational capacity, CPV – competing public values, HaCPV – handling of competing public values. ¥ - Articles mentioned at least one CPV or an approach for HaCPV
| Item and its interpretation | Code |
|---|---|
| 1. Level of migration governance: | |
| • Bilateral agreements/initiatives: | Bil.Agree/Init |
| • Regional agreements/initiatives: | Reg.Agree/Init |
| • International agreements/initiatives: | Int.Agree/Init |
| 2. What was the public value proposition offered by agreement/governance initiative? | Main.Aim |
| 3. Were there competing public values (i.e. competing aims between participating countries)? If yes, please code them. |
Economic values: Pub.Val_Econ Social & cultural value:Pub.Val_Soc.Cult Political value:Pub.Val_Pol Ecological value:Pub.Val_Ecol Social value:Pub.Val_Soc Protecting citizen’s/migrant rights: Pub.Val_Rights |
| 5. How were these competing public values handled? Codes for this section include: |
Solidarity: Comp.Pub.Val_Sol Autonomy:Comp.Pub.Val_Aut Equality and Equity:Comp.Pub.Val_EE Authority:Comp.Pub.Val_Auth |
| 7. Enabling and Constraining Factors? | Ena/Cons |
| 8. Provide information on what changed concerning health professional migration between participating countries. | Chang.Mig |
| SECTION | ITEM | PRISMA-ScR CHECKLIST ITEM | REPORTED ON PAGE # |
|---|---|---|---|
| TITLE | |||
| Title | 1 | Identify the report as a scoping review. | 1 |
| ABSTRACT | |||
| Structured summary | 2 | Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, charting methods, results, and conclusions that relate to the review questions and objectives. | 2 |
| INTRODUCTION | |||
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. Explain why the review questions/objectives lend themselves to a scoping review approach. | 4 |
| Objectives | 4 | Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g. population or participants, concepts, and context) or other relevant key elements used to conceptualize the review questions and/or objectives. | 5 |
| METHODS | |||
| Protocol and registration | 5 | Indicate whether a review protocol exists; state if and where it can be accessed (e.g. a Web address); and if available, provide registration information, including the registration number. | 5 |
| Eligibility criteria | 6 | Specify characteristics of the sources of evidence used as eligibility criteria (e.g. years considered, language, and publication status), and provide a rationale. | 6 |
| Information sources* | 7 | Describe all information sources in the search (e.g. databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed. | 7 |
| Search | 8 | Present the full electronic search strategy for at least 1 database, including any limits used, such that it could be repeated. | |
| Selection of sources of evidence† | 9 | State the process for selecting sources of evidence (i.e. screening and eligibility) included in the scoping review. | 7 |
| Data charting process‡ | 10 | Describe the methods of charting data from the included sources of evidence (e.g. calibrated forms or forms that have been tested by the team before their use, and whether data charting was done independently or in duplicate) and any processes for obtaining and confirming data from investigators. | 8 |
| Data items | 11 | List and define all variables for which data were sought and any assumptions and simplifications made. | 8 |
| Critical appraisal of individual sources of evidence§ | 12 | If done, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods used and how this information was used in any data synthesis (if appropriate). | N/A |
| Synthesis of results | 13 | Describe the methods of handling and summarizing the data that were charted. | 8 |
| RESULTS | |||
| Selection of sources of evidence | 14 | Give numbers of sources of evidence screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram. | |
| Characteristics of sources of evidence | 15 | For each source of evidence, present characteristics for which data were charted and provide the citations. | |
| Critical appraisal within sources of evidence | 16 | If done, present data on critical appraisal of included sources of evidence (see item 12). | N/A |
| Results of individual sources of evidence | 17 | For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives. | |
| Synthesis of results | 18 | Summarize and/or present the charting results as they relate to the review questions and objectives. | |
| DISCUSSION | |||
| Summary of evidence | 19 | Summarize the main results (including an overview of concepts, themes, and types of evidence available), link to the review questions and objectives, and consider the relevance to key groups. | 17 |
| Limitations | 20 | Discuss the limitations of the scoping review process. | 21 |
| Conclusions | 21 | Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications and/or next steps. | 21 |
| FUNDING | |||
| Funding | 22 | Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review. | 23 |
JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews.
* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites.
† A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g. quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote).
‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting.
§ The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of ‘risk of bias’ (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g. quantitative and/or qualitative research, expert opinion, and policy document).
From: Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18-0850.